The IPOX® Week, January 10th, 2022

  • Ahead of earnings, IPOX® Indexes in broad retreat. Weak bonds, jump in risk (VIX: +8.94%) weigh.
  • IPOX® 100 Index (ETF: FPX) drop Concern of a Bumby 2022? A look at history.
  • IPOX® SPAC (SPAC) sheds -2.37%. 4 new SPACs launched last week.
  • 5 IPOs commence trading. Private Equity giant TPG Partners (TPG US) set for Thursday debut.

Last week’s Summary:  The IPOX® Indexes retreated broadly during the first week of the New Year as the asset allocation shifts away from high growth and relatively unseasoned equities continued across the global regions. Ahead of earnings season, rising U.S. rates amid updated FED tightening expectations and higher equity risk (VIX: +8.94%) weighed on sentiment. In the U.S., for example, the IPOX® 100 U.S. (ETF: FPX) fell to -6.33% YTD, lagging the Nasdaq 100 (ETF: QQQ), but significantly leading other innovation-focused ETFs (ETF: ARKK) for another week. Declines in the index were broad-based with 84/100 portfolio holdings closing the first week of 2022 in negative territory, with big declines amongst a slew of technology and health care stocks driving the average (median) decline to -6.39% (-6.80%), underperforming the applied market-cap weighted IPOX® 100 U.S. Index (ETF: FPX). Declines extended to IPOX® Indexes tracking the performance of New Listings in other world regions, including the IPOX® 100 Europe (ETF: FPXE), IPOX® Nordic (IPND) and IPOX® International (ETF: FPXI). We note the continued relative strength in the IPOX® Growth Infusion (GNDX) Index a broad-based portfolio of incumbent companies pursuing global IPO M&A. Driven by big gains across Energy and Financials, the strategy declined to just -1.33% YTD, outpacing the S&P 500 (ETF: SPY) by +54 bps. last week.

IPOX® Portfolio Holdings in focus:  Upside upside focus was on bank, energy and auto (supplier) exposure, with IPO M&A play Keycorp (KEY US: +13.92%), oilfield technology provider Spin-off Championx (CHX US: +13.26%), car maker Volvo Car (VOLCARB SS: +6.70%) and AXA-Spin-off Equitable (EQH US: +8.23%) leading the way, with many (unseasoned) technology and health care stocks in the respective IPOX® Portfolios suffering sharp declines ahead of earnings.

IPOX® 100 Index Performance and End-of-Year Returns (since 1989)

  first 5 trading days Year-end
Returns (%) Average median Average Median
All Years (12) -3.72 -3.14 8.93 15.73
excluding:  
Internet bubble (1) -3.45 -2.89 15.51 20.57
FInancial CrisIs (2) -3.31 -2.90 13.77 20.44
(1) + (2) -2.92 -2.88 22.15 20.70

IPOX® 100 INDEX (etf: fpx) DROP A CONCERN OF A BUMPY 2022? The IPOX® 100 U.S. Index (ETF: FPX) started 2022 with losses (after a lackluster 2021 and strong 2020), with higher interest rates perceived to drive investors to unload positions in some of the high-growth, high-valuation stocks with limited stock market history typically tracked in the IPOX® Portfolios. In the table above, we look at some historical context to study the historic link between negative year-open performances and respective end of year returns.  During 32 years of IPOX® 100 U.S. (ETF: FPX) history (and based on the first 5 trading days of a New Year, respectively), the index closed negative 12 times, recording an average (median) drop of -3.72% (-3.14%). Negative returns recorded during the first five trading days, however, do not seem to be indicative of negative calendar year returns with the IPOX® 100 Index (ETF: FPX) rising by an average (median) of +8.93% (+15.73%). When removing the year of the Financial Crisis (2008) as a systemic event, the average (median) return jumps to +13.77% (+20.44%).

Select IPOX® Indexes PRICE Returns 2020 2021 YTD
IPOX® Indexes: Global/International
IPOX® Global Super Liquid (IPGL50) (USD) 66.63 -4.01 -7.56
IPOX® International (IPXI) (USD) (ETF: FPXI) 72.15 -15.57 -5.05
IPOX® Indexes: United States
IPOX® 100 U.S. (IPXO)* (USD) (ETF: FPX) 47.32 3.70 -6.33
IPOX® GROWTH INFUSION (GNDX) * (USD) n/a 9.42 -1.33
IPOX® ESG (IPXT) (USD) 42.29 -0.62 -6.90
IPOX® SPAC (SPAC) (USD) 48.53 -16.34 -2.37
IPOX® EV (IPEV) (USD) 11.02 27.06 -2.92
IPOX® Indexes: Europe/Nordic
IPOX® Europe (IPOE) * (USD) (ETF: FPXE) 35.14 9.09 -6.08
IPOX® Nordic Core (IPND) (EUR) 59.87 20.34 -5.23
IPOX® Indexes: Asia-Pacific/China
IPOX® Asia-Pacific (IPTA) (USD) 47.50 -9.66 -2.54
IPOX® China Core (CNI) (USD) 88.02 -42.62 -6.41
IPOX® Japan (IPJP) (JPY) 25.75 3.42 -7.84

* Basis for CME-traded e-mini IPOX® 100 U.S. Futures (IPOH2). *Also available in UCITS format in Europe in EUR (EFPX IM), USD (IPXE LN), and GBP (FPX LN). GNDX, SPAC and IPEV returns measured since live launch on 08/13/2021, 07/30/2020 and 11/17/2020.

IPOX® SPAC INDEX (SPAC) REVIEW:  The Index fell -2.37% on the week to +21.31% since Its 7/30/2020 live launch. SPACs news include: 1) No SPACs Announced Merger Agreement during the first year of the New Year. 2) 1 SPAC Approved Business Combinations include a) VPC Impact Acquisition III (VPCB US: +0.40%) with LA-based banking app Dave (DAVE: -43.51%). 3) 4 new SPACs launched last week In the U.S.

Weekly GLOBAL Deal-flow Review and Outlook:  6 sizeable IPOs launched, with the average (median) equally weighted deal adding +62.54% (+5.01%) based on the difference between the final offering price and Friday’s close, respectively. Saudi online food delivery start-up Jahez International (JAHEZ AB: +10.02%) and Indonesia’s coal miner Adaro Mineral Indonesia (ADMR IJ: +280.00%) tripled in its Monday stock market debut. In the United States, sentiment for small-cap IPOs in the biotech space remained subdued, underlined by negative initial returns recorded by Amylyx Pharma (AMLX US: -4.89%) and Vigil Neuroscience (VIGL US: -9.64%), while CinCor Pharma (CINC US) traded flat. Big upside in online retailer micro-cap Hour Loop (HOUR US: +99.75%) underlines interest for specialty consumer deals. Following big 2021 returns for the industry, notable upcoming IPOs this week include U.S.-traded Private Equity giant JP Morgan-led TPG Partners (TPG US), human capital management (HCM) software platform Justworks (JW US), micro-cap kitchen and bath product supplier FGI Industries (FGI US) and biotech Hillstream Biopharma (HILS US). Select other IPO news include a) Social media firm Reddit choses Morgan Stanley and Goldman Sachs for upcoming blockbuster IPO and b) Tencent-backed online car services platform Tuhu shifts its upcoming IPO from the United States to Hong Kong.

Lightspeed Financial Services Group LLC is not affiliated with these third-party market commentators/educators or service providers. Data, information, and material (“content”) are provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities or contracts. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lightspeed Financial Services Group LLC does not endorse, offer nor recommend any of the services or commentary provided by any of the market commentators/educators or service providers and any information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

The IPOX® Week, January 3rd, 2022
Read More
The IPOX® Week, December 27th, 2021
Read More
Timing Is Everything For Successful Traders
Read More
How Traders Use Options To Gain Leverage
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.

OK